| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2012-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103539731-B |
| titleOfInvention |
Amides compound of pyridine 2 and preparation method thereof, its pharmaceutical composition and purposes |
| abstract |
The present invention relates to amides compound of pyridine 2 shown in below formula I and preparation method thereof, its pharmaceutical composition and purposes.The compound is used to prepare medicine of the treatment by the integrase mediated disease of a variety of retrovirals including the integrases of HIV 1 as integrase inhibitor. |
| priorityDate |
2012-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |